Victims, families gain key role in Purdue Pharma bankruptcy case
Victims of opioid addiction weren't in the room when OxyContin maker Purdue Pharma persuaded half the state attorneys general to settle claims over the company's role in the nationwide overdose epidemic. Now that Purdue is in federal bankruptcy court, four people whose lives were touched ...
The Drug Enforcement Administration was "slow to respond" as America grappled with a rising opioid epidemic, the Justice Department's inspector general said in a report Tuesday that faulted the agency for cutting back use of a key enforcement tool and continuing to raise production ...
Complicity, opioids and vaping — a bad mix
Johnson & Johnson appeals Oklahoma judge's $572 million ruling over opioid crisis
Consumer products giant Johnson & Johnson is appealing an Oklahoma judge's $572 million order against the company and its subsidiaries for helping fuel the state's opioid crisis. The company filed an appeal with the Oklahoma Supreme Court on Wednesday, arguing the ruling was an "unprecedented ...
After deluge of lawsuits, OxyContin maker Purdue Pharma files for bankruptcy protection
OxyContin maker Purdue Pharma LP filed for bankruptcy protection Sunday night, succumbing to pressure from more than 2,600 lawsuits alleging the company helped fuel the deadly U.S. opioid epidemic. Purdue's board met Sunday evening to approve the long-expected bankruptcy filing, which the company is pursuing ...
Purdue Pharma opioid plan pits U.S. state against state over epidemic's cost
Purdue Pharma, maker of the highly addictive painkiller Oxycontin, is pitting state against state with an offer of about $12 billion to resolve the company's liability for the massive public health crisis tied to opioid abuse that has swept the U.S. Almost half of the ...
OxyContin maker Purdue Pharma LP reached a tentative agreement with some plaintiffs to resolve widespread litigation over its alleged role in fueling the U.S. opioid crisis and plans to tussle with states opposing its settlement offer in bankruptcy proceedings starting as soon as next ...
OxyContin maker Purdue prepares 'free-fall' bankruptcy as settlement talks stall, sources say
OxyContin maker Purdue Pharma LP is preparing to seek bankruptcy protection before the end of the month if it does not reach a settlement with U.S. communities over widespread opioid litigation, three people familiar with the matter said, after some states balked at the ...
OxyContin maker Purdue Pharma LP and its owners, the Sackler family, are in discussion to settle more than 2,000 lawsuits against the company for $10 billion to $12 billion, two people familiar with the matter said on Tuesday. Purdue is among several drug-makers and distributors ...
While some Johnson & Johnson investors were relieved that the company's $572 million penalty for fueling Oklahoma's opioid epidemic wasn't as high as feared, lawyers for other U.S. states, cities and counties could hardly contain their glee. That's because the ruling by Oklahoma Judge Thad ...
J&J ordered to pay $572 million to clean up Oklahoma's deadly opioid crisis
An Oklahoma judge on Monday found Johnson & Johnson and its subsidiaries helped fuel the state's opioid crisis and ordered the consumer products giant to pay $572 million to clean up the problem. Cleveland County District Judge Thad Balkman's ruling followed the first state opioid ...
U.S. President Donald Trump's administration on Wednesday announced a plan that would allow the importation of lower-cost prescription drugs from Canada, in a move denounced as "dangerous" by the pharmaceuticals industry. Americans spend an average of $1,200 on prescription drugs per year, according to the ...
